Drug Type Cell therapy |
Synonyms QH 103, QH103 |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pre B-cell acute lymphoblastic leukemia | Phase 1 | CN | 27 Sep 2023 |